Cell-penetrating peptide-conjugated lipid nanoparticles for siRNA deliveryTomohiro Asai, Naoto Oku, Kenji Hyodo et al.|Biochemical and Biophysical Research Communications|2014Cited by 84
Systemic Administration of siRNA with Anti-HB-EGF Antibody-Modified Lipid Nanoparticles for the Treatment of Triple-Negative Breast CancerAyaka Okamoto, Naoto Oku, Tomohiro Asai et al.|Molecular Pharmaceutics|2018Cited by 77
Reprogramming of the Developmental Program of Rhus javanica During Initial Stage of Gall Induction by Schlechtendalia chinensisTomoko Hirano, Masa H. Sato, Seisuke Kimura et al.|Frontiers in Plant Science|2020Cited by 51
Advanced cancer therapy by integrative antitumor actions via systemic administration of miR-499Hidenori Ando, Naoto Oku, Tomohiro Asai et al.|Journal of Controlled Release|2014Cited by 43
Antibody-modified lipid nanoparticles for selective delivery of siRNA to tumors expressing membrane-anchored form of HB-EGFAyaka Okamoto, Naoto Oku, Tomohiro Asai et al.|Biochemical and Biophysical Research Communications|2014Cited by 43